Description
Celyra Bio is a start-up project set to solve the limitations in exosome production, by betting on pluripotent stem cells and machine learning optimization. Our platform combines stem cells from different species to circumvent regulatory hurdles across regions and to unlock novel exosome bioactive profiles. The plan is to target dermo-cosmetics first, as they offer a faster market entry and an opportunity to de-risk the business before expanding to the field of therapeutics.
